New alliance aims to accelerate development of future medicines

KUP101 enters clinic for advanced solid tumours

SMC acceptance offers new option for patients

Delayed‑release mercaptamine approved for routine use

Stablepharma’s thermostable td shot delivers strong phase 1 data

Regulator backs gene therapy for PKP2-ACM

Programme celebrates partnership excellence

Acalabrutinib combinations approved for CLL and MCL

First patient enrolled in Agni-01 expansion

Postmenopausal study highlights oral anabolic potential